PPARG and Hepatitis: These findings in GalN/LPS hepatitis were unexpected as it has been reported that increased hepatic PPARγ expression during GalN/LPS hepatitis was associated with decreased severity [12], and we observed that isolated immune cell populations, such as LSEC and T cells, responded to pharmacologic PPARγ activation with reduced pro-inflammatory cytokine production.